Cyclerion Therapeutics (CYCN) Enterprise Value (2019 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Enterprise Value of -$3.2 million for Q4 2025, little changed year-over-year from -$3.2 million in Q4 2024, and up 29.07% quarter-over-quarter from -$4.6 million in Q3 2025.
Cyclerion Therapeutics (CYCN) Enterprise Value (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- In Q4 2025, Enterprise Value changed 0.25% year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$3.2 million (changed 0.25% YoY), while the FY2025 annual figure was -$3.2 million, changed 0.25% from the prior year.
- Enterprise Value for Q4 2025 stood at -$3.2 million, up from -$4.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$2.9 million in Q3 2024, with the low at -$70.4 million in Q2 2021.
- The 5-year median for Enterprise Value is -$7.4 million (2023), against an average of -$19.7 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 82.56% in 2023, then tumbled 59.05% in 2025.
- Cyclerion Therapeutics' Enterprise Value stood at -$54.0 million in 2021, then jumped by 75.2% to -$13.4 million in 2022, then jumped by 43.42% to -$7.6 million in 2023, then jumped by 57.31% to -$3.2 million in 2024, then retreated by 0.25% to -$3.2 million in 2025.
- Business Quant data shows CYCN's Enterprise Value at -$3.2 million in Q4 2025, -$4.6 million in Q3 2025, and -$3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 2.12 Bn |
| 10 | Cyclerion Therapeutics | 12.29 Mn | 9.05 Mn | - | -3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.24 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -3.64 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -2.87 Mn |
| Jun 30, 2024 | -4.59 Mn |
| Mar 31, 2024 | -5.70 Mn |
| Dec 31, 2023 | -7.57 Mn |
| Sep 30, 2023 | -9.11 Mn |
| Jun 30, 2023 | -5.64 Mn |
| Mar 31, 2023 | -7.17 Mn |
| Dec 31, 2022 | -13.38 Mn |
| Sep 30, 2022 | -20.41 Mn |
| Jun 30, 2022 | -30.32 Mn |
| Mar 31, 2022 | -41.10 Mn |
| Dec 31, 2021 | -53.96 Mn |
| Sep 30, 2021 | -62.50 Mn |
| Jun 30, 2021 | -70.39 Mn |
| Mar 31, 2021 | -41.43 Mn |